These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

741 related items for PubMed ID: 17619064

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
    Elder DP, Holm R, Diego HL.
    Int J Pharm; 2013 Aug 30; 453(1):88-100. PubMed ID: 23182973
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Selection of a Pharmaceutical Salt-The Effect of the Acidity of the Counterion on Its Solubility and Potential Biopharmaceutical Performance.
    He Y, Orton E, Yang D.
    J Pharm Sci; 2018 Jan 30; 107(1):419-425. PubMed ID: 29107790
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Microenvironmental pH modulation in solid dosage forms.
    Badawy SI, Hussain MA.
    J Pharm Sci; 2007 May 30; 96(5):948-59. PubMed ID: 17455349
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA, Ji Q, Joshi YM, Serajuddin AT.
    Int J Pharm; 2007 Jun 07; 337(1-2):210-8. PubMed ID: 17296277
    [Abstract] [Full Text] [Related]

  • 11. Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.
    Cavanagh KL, Maheshwari C, Rodríguez-Hornedo N.
    J Pharm Sci; 2018 Jan 07; 107(1):113-120. PubMed ID: 29097226
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Salt disproportionation: A material science perspective.
    Thakral NK, Kelly RC.
    Int J Pharm; 2017 Mar 30; 520(1-2):228-240. PubMed ID: 28163222
    [Abstract] [Full Text] [Related]

  • 15. Disproportionation of Pharmaceutical Salts: pHmax and Phase-Solubility/pH Variance.
    Avdeef A.
    Mol Pharm; 2021 Jul 05; 18(7):2724-2743. PubMed ID: 34142831
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Salt Solubility and Disproportionation - Uses and Limitations of Equations for pHmax and the In-silico Prediction of pHmax.
    Avdeef A, Sugano K.
    J Pharm Sci; 2022 Jan 05; 111(1):225-246. PubMed ID: 34863819
    [Abstract] [Full Text] [Related]

  • 18. Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database.
    Paulekuhn GS, Dressman JB, Saal C.
    J Med Chem; 2007 Dec 27; 50(26):6665-72. PubMed ID: 18052022
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.